Vedolizumab Suppliers & Bulk Manufacturers
Available Forms: Injection / infusion
Available Strengths: 300mg, 108 mg/0.68 mL
Reference Brands: ENTYVIO (USA/EU)
Category: Gastrointestinal Drugs
Vedolizumab is a gut-selective monoclonal antibody that blocks the α4β7 integrin, preventing white blood cells from migrating into inflamed gastrointestinal tissue. It is used to treat adults with moderate to severe ulcerative colitis or Crohn’s disease who have not responded adequately to conventional therapies. Entyvio is administered either as an intravenous infusion (300 mg) or subcutaneous injection (108 mg). The drug is known for its targeted mechanism that reduces systemic immunosuppression compared to other biologics. Vedolizumab is available in Injection / infusion and strengths such as 300mg, 108 mg/0.68 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vedolizumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Vedolizumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Vedolizumab is used to treat moderate to severe ulcerative colitis and Crohn’s disease in adults. It helps reduce inflammation in the digestive tract and maintain remission by blocking the movement of inflammatory white blood cells (lymphocytes) into the gut, which are responsible for causing inflammation.
Vedolizumab is made from Vedolizumab, a humanized monoclonal antibody that targets the α4β7 integrin receptor on gut-specific lymphocytes, thereby preventing their migration to inflamed intestinal tissue.
The trade name of Vedolizumab is Entyvio.
Vedolizumab (En tyvio)is developed and manufactured by Takeda Pharmaceutical Company Limited, Japan, and marketed globally under regulatory approvals.
The generic name of Vedolizumab is Vedolizumab.
The brand name of Vedolizumab is Entyvio.
Vedolizumab is manufactured by Takeda Pharmaceutical Company in Japan and its production facilities in the United States and Europe under strict GMP guidelines.
Related Products
Naloxegol Oxalate
Strength:
12.5 mg, 25 mg
Form: Tablets
Reference Brands: Movantik (USA), Moventig (EU)
View Details
Methscopolamine Bromide
Strength:
2.5 mg, 5 mg
Form: Tablets
Reference Brands: Pamine (USA)
View Details
Linaclotide
Strength:
72 mcg, 145 mcg, 290 mcg
Form: Capsules
Reference Brands: Linzess (USA), Constella (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
